Acurx Pharmaceuticals Inc...
(ACXP)
undefined
undefined%
At close: undefined
0.81
-4.15%
Pre-market Dec 16, 2024, 05:59 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Cash & Equivalents | 7.47M | 9.11M | 12.96M | 3.18M | 2.48M |
Short-Term Investments | - | - | - | - | - |
Long-Term Investments | - | - | - | - | - |
Other Long-Term Assets | - | - | - | - | - |
Receivables | 129.16K | - | - | - | - |
Inventory | - | - | - | - | - |
Other Current Assets | 105.78K | 264.95K | 295.30K | 48.61K | 48.10K |
Total Current Assets | 7.71M | 9.38M | 13.25M | 3.22M | 2.53M |
Property-Plant & Equipment | - | - | - | - | - |
Goodwill & Intangibles | - | - | - | - | - |
Total Long-Term Assets | - | - | - | - | - |
Total Assets | 7.71M | 9.38M | 13.25M | 3.22M | 2.53M |
Account Payables | 3.81K | 29.54K | 63.37K | - | 2.30K |
Deferred Revenue | - | - | - | - | - |
Short-Term Debt | - | - | - | 16.63K | - |
Other Current Liabilities | 3.04M | 2.03M | 780.53K | 455.93K | 1.71M |
Total Current Liabilities | 3.04M | 2.06M | 843.91K | 472.56K | 1.71M |
Long-Term Debt | - | - | - | 49.88K | - |
Other Long-Term Liabilities | - | - | - | - | - |
Total Long-Term Liabilities | - | 2.06M | - | 49.88K | - |
Total Liabilities | 3.04M | 2.06M | 843.91K | 522.43K | 1.71M |
Total Debt | - | - | - | 66.50K | - |
Common Stock | 14.47K | 11.63K | 10.22K | 16.50M | 10.02M |
Retained Earnings | -53.22M | -38.64M | -26.55M | -13.80M | -9.20M |
Comprehensive Income | - | -38.64M | -26.55M | -13.80M | -9.20M |
Shareholders Equity | 4.67M | 7.32M | 12.41M | 2.70M | 819.85K |
Total Investments | - | - | - | - | - |